Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.
Quercis Pharma has raised $150.0M in total funding. The most recent round was Private Equity. The last funding was announced in December 2021.
Quercis Pharma's investors include The Global Emerging Markets Group.
Quercis Pharma is headquartered in Zug, Switzerland.
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.
Quercis Pharma is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quercis Pharma — Funding & Investors." VCBacked, December 9, 2021, https://www.vcbacked.co/company/quercis-pharma. Accessed November 13, 2026.
VCBacked. (2021). Quercis Pharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/quercis-pharma
{{cite web |title=Quercis Pharma — Funding & Investors |url=https://www.vcbacked.co/company/quercis-pharma |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Quercis Pharma? Request a listing update